Placental Stem Cell Therapy Market, By Therapy Type (Allogeneic Therapy and Autologous Therapy), By Cell Type, By End-user, By Application, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4517
|
Published Date
November 2025
|
Pages
355
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
The Placental Stem Cell Therapy Market size was valued at US$ 455 Million in 2024, expanding at a CAGR of 18.5% from 2025 to 2032.
Placental Stem Cell Therapy utilizes stem cells derived from the placenta to treat neurological and other disorders. The market is being driven by the growing focus on regenerative medicine, as placental stem cells have the potential to repair or replace damaged neurons, offering solutions for unmet medical needs in neurological conditions. Advances in biotechnology, stem cell isolation, and expansion techniques are accelerating adoption and fueling market growth. However, regulatory hurdles remain a key challenge, with stringent approval processes increasing development timelines and costs. In addition, the high cost of therapies limits patient accessibility, restricting broader market penetration despite the rising clinical interest. The Canadian Stem Cell Network (SCN) is another case in point — funded by the Canadian government, it secured CAD45million for its 2022–2025 research cycle.
Placental Stem Cell Therapy Market- Market Dynamics
Technological Advances and Innovative Research Driving Market Growth
Technological innovation and advanced research are key drivers of growth in the placental stem cell therapy market. Cutting-edge technologies are enhancing the isolation, processing, and therapeutic application of stem cells, improving both treatment efficacy and safety. For example, in November 2023, researchers from the Singapore-MIT Alliance for Research and Technology (SMART) Critical Analytics for Manufacturing Personalized Medicine (CAMP) Interdisciplinary Research Group (IRG), in collaboration with ASTAR’s Bioprocessing Technology Institute (BTI) and the National University Health System (NUHS), developed a method to extract mesenchymal stem cells (MSCs) directly from pure bone marrow aspirate, significantly streamlining the process. Such breakthroughs underscore the pivotal role of innovation in expanding market potential.
Placental Stem Cell Therapy Market- Segmentation Analysis:
The worldwide market is segmented on the basis of Therapy Type, Cell Type, End-user, Application, and Region.
The therapy type segment of the placental stem cell therapy market is primarily divided into Allogeneic and Autologous therapies. Allogeneic therapies represent a key segment due to their “off-the-shelf” availability. These donor-derived cell products can be cryopreserved and administered immediately, making them ideal for emergency neurological interventions where rapid treatment is critical. This operational advantage eliminates the time and cost associated with patient-specific autologous cell harvesting. Regulatory support further strengthens this segment; in 2023, the World Health Organization endorsed updated global principles for human cell and tissue therapies, enhancing quality, traceability, and safety standards across member states and enabling wider deployment of allogeneic cell products. National policies are also accelerating scale-up—for instance, Japan’s PMDA approved over 20 new cell- and tissue-based therapy trials between 2022 and 2024, many utilizing allogeneic cell banking to reduce manufacturing timelines. These clinical and regulatory trends position allogeneic placental stem cell therapies as a strategic growth driver in the market.
In terms of end users, academic and research institutions play a critical role in advancing placental stem cell therapies. Their work focuses on elucidating the biology, safety, and therapeutic potential of placenta-derived mesenchymal stromal cells (MSCs), as well as developing GMP-compliant manufacturing protocols and preclinical efficacy models. For example, a 2024 study published in Frontiers in Bioscience by a university-affiliated research center demonstrated that human placenta-derived MSCs significantly improved neurological outcomes in a rat model of hypoxic-ischemic encephalopathy by reducing inflammation and neuronal apoptosis, highlighting the translational potential of these therapies.
Placental Stem Cell Therapy Market- Geographical Insights
North America holds a significant share of the placental stem cell therapy market, driven by growing awareness of the therapeutic potential of placental stem cells in treating neurological disorders. Rising patient interest in alternative and advanced treatments, coupled with continuous advancements in therapy development, is fueling market expansion. Collaborative efforts among academic institutions, healthcare providers, and biotechnology companies have led to the establishment of specialized facilities, improved accessibility, and enabled broader clinical application of placental stem cell therapies for neurological conditions. Globally, government support is strengthening this trend—for instance, in 2023, the World Health Organization issued updated guidelines on human cell and tissue-based therapies, promoting standardized safety, quality, and traceability practices across member states, which facilitates wider adoption and clinical deployment of placental stem cell therapies worldwide.
United States Placental Stem Cell Therapy Market- Country Insights
The United States is a key revenue driver in the placental stem cell therapy market for neurological disorders, fueled by the rising prevalence of age-related conditions such as Alzheimer’s and Parkinson’s disease. By 2050, the number of Americans aged 65 and older living with Alzheimer’s is projected to reach 13 million, up from approximately 7.2 million in 2025. In 2024, nearly 12 million Americans provided unpaid care for individuals with dementia, underscoring the urgent need for effective interventions. Furthermore, nearly one million Americans are affected by Parkinson’s disease, with risk increasing significantly with age. These statistics highlight the growing demand for innovative therapies, positioning placental stem cell treatments as a critical option for addressing neurological disorders in the U.S.
Placental Stem Cell Therapy Market- Competitive Landscape:
The placental stem cell therapy market is moderately concentrated, with a few leading players driving innovation and expanding their global reach. Key companies such as Thermo Fisher Scientific, Inc., Cell Applications, Inc., Bio-Techne, and Cellular Engineering Technologies focus on developing advanced stem cell therapies for neurological and other degenerative disorders. These companies compete by advancing cell isolation, storage, and delivery technologies to enhance safety, efficacy, and patient outcomes. For instance, in February 2024, Pluristem Therapeutics announced a strategic partnership with a U.S.-based biopharmaceutical company to accelerate clinical trials of placental-derived mesenchymal stem cells for ischemic stroke and facilitate rapid market entry. Continuous R&D investment, collaborations with academic institutions, and regulatory approvals that support commercialization are shaping competitive dynamics. Expansion strategies include strengthening manufacturing capabilities and targeting emerging markets to meet the growing global demand for regenerative therapies.
Recent Developments:
- In December 2024, Mesoblast Limited announced that Ryoncil (remestemcel-L) received FDA approval as the first mesenchymal stromal cell (MSC) therapy in the United States. Ryoncil is also the first treatment approved for steroid-resistant acute graft-versus-host disease (SR-aGvHD) in children as young as two months, including adolescents. Dr. Joanne Kurtzberg of Duke University Medical Center highlighted that Ryoncil provides a life-saving option for pediatric patients with this severe condition.
- In October 2024, Aspen Neuroscience, Inc. expanded its San Diego operations with a new 22,000-square-foot GMP facility for manufacturing induced pluripotent stem cell (iPSC)-based therapies. The facility will produce ANPD001, an iPSC-derived therapy for Parkinson’s disease under the ASPIRO trial. The expansion features ISO-certified manufacturing suites, quality control labs, and enhanced capacity for automation, aiming to industrialize autologous cell therapy production and improve throughput.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PLACENTAL STEM CELL THERAPY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Thermo Fisher Scientific, Inc
- Cell Applications, Inc.
- Bio-Techne
- Cellular Engineering Technologies
- AlloSource
- STEMCELL Technologies, Inc.
- PromoCell GmbH
- Takara Holdings, Inc.
- Lonza
- Merck KGaA
- Sartorius AG (CellGenix GmbH)
- ATCC
- AcceGen
- Mesoblast Ltd
- Others
GLOBAL PLACENTAL STEM CELL THERAPY MARKET, BY THERAPY TYPE- MARKET ANALYSIS, 2019 - 2032
- Allogeneic Therapy
- Autologous Therapy
GLOBAL PLACENTAL STEM CELL THERAPY MARKET, BY CELL TYPE- MARKET ANALYSIS, 2019 - 2032
- Mesenchymal Stem Cells (MSCs)
- Endothelial Progenitor Cells (EPCs)
- Umbilical-Derived MSCs
- Hematopoietic Stem Cells (HSCs)
- Placental-Derived MSCs
- Mixed/Co-Culture Stem Cells
GLOBAL PLACENTAL STEM CELL THERAPY MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals & Specialty Clinics
- Research & Academic Institutes
- Biopharmaceutical Companies
- Contract Research Organizations (CROs)
GLOBAL PLACENTAL STEM CELL THERAPY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Hematologic Malignancies and Disorders
- Metabolic Disorders
- Neurological Disorders
- Congenital Immunodeficiency Disorders
- Others
GLOBAL PLACENTAL STEM CELL THERAPY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Placental Stem Cell Therapy Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Placental Stem Cell Therapy Market Snippet by Therapy Type
2.1.2. Placental Stem Cell Therapy Market Snippet by Cell Type
2.1.3. Placental Stem Cell Therapy Market Snippet by End-user
2.1.4. Placental Stem Cell Therapy Market Snippet by Application
2.1.5. Placental Stem Cell Therapy Market Snippet by Country
2.1.6. Placental Stem Cell Therapy Market Snippet by Region
2.2. Competitive Insights
3. Placental Stem Cell Therapy Key Market Trends
3.1. Placental Stem Cell Therapy Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Placental Stem Cell Therapy Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Placental Stem Cell Therapy Market Opportunities
3.4. Placental Stem Cell Therapy Market Future Trends
4. Placental Stem Cell Therapy Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Placental Stem Cell Therapy Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Placental Stem Cell Therapy Market Landscape
6.1. Placental Stem Cell Therapy Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Placental Stem Cell Therapy Market – By Therapy Type
7.1. Overview
7.1.1. Segment Share Analysis, By Therapy Type, 2024 & 2032 (%)
7.1.2. Allogeneic Therapy
7.1.3. Autologous Therapy
8. Placental Stem Cell Therapy Market – By Cell Type
8.1. Overview
8.1.1. Segment Share Analysis, By Cell Type, 2024 & 2032 (%)
8.1.2. Mesenchymal Stem Cells (MSCs)
8.1.3. Endothelial Progenitor Cells (EPCs)
8.1.4. Umbilical-Derived MSCs
8.1.5. Hematopoietic Stem Cells (HSCs)
8.1.6. Placental-Derived MSCs
8.1.7. Mixed/Co-Culture Stem Cells
9. Placental Stem Cell Therapy Market – By End-user
9.1. Overview
9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
9.1.2. Hospitals & Specialty Clinics
9.1.3. Research & Academic Institutes
9.1.4. Biopharmaceutical Companies
9.1.5. Contract Research Organizations (CROs)
10. Placental Stem Cell Therapy Market – By Application
10.1. Overview
10.1.1. Segment Share Analysis, By Cell Type, 2024 & 2032 (%)
10.1.2. Hematologic Malignancies and Disorders
10.1.3. Metabolic Disorders
10.1.4. Neurological Disorders
10.1.5. Congenital Immunodeficiency Disorders
10.1.6. Others
11. Placental Stem Cell Therapy Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Placental Stem Cell Therapy Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Placental Stem Cell Therapy Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Placental Stem Cell Therapy Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Placental Stem Cell Therapy Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Placental Stem Cell Therapy Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Placental Stem Cell Therapy Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Thermo Fisher Scientific, Inc
12.2.2. Cell Applications, Inc.
12.2.3. Bio-Techne
12.2.4. Cellular Engineering Technologies
12.2.5. AlloSource
12.2.6. STEMCELL Technologies, Inc.
12.2.7. PromoCell GmbH
12.2.8. Takara Holdings, Inc.
12.2.9. Lonza
12.2.10. Merck KGaA
12.2.11. Sartorius AG (CellGenix GmbH)
12.2.12. ATCC
12.2.13. AcceGen
12.2.14. Mesoblast Ltd
12.2.15. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PLACENTAL STEM CELL THERAPY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Thermo Fisher Scientific, Inc
- Cell Applications, Inc.
- Bio-Techne
- Cellular Engineering Technologies
- AlloSource
- STEMCELL Technologies, Inc.
- PromoCell GmbH
- Takara Holdings, Inc.
- Lonza
- Merck KGaA
- Sartorius AG (CellGenix GmbH)
- ATCC
- AcceGen
- Mesoblast Ltd
- Others
GLOBAL PLACENTAL STEM CELL THERAPY MARKET, BY THERAPY TYPE- MARKET ANALYSIS, 2019 - 2032
- Allogeneic Therapy
- Autologous Therapy
GLOBAL PLACENTAL STEM CELL THERAPY MARKET, BY CELL TYPE- MARKET ANALYSIS, 2019 - 2032
- Mesenchymal Stem Cells (MSCs)
- Endothelial Progenitor Cells (EPCs)
- Umbilical-Derived MSCs
- Hematopoietic Stem Cells (HSCs)
- Placental-Derived MSCs
- Mixed/Co-Culture Stem Cells
GLOBAL PLACENTAL STEM CELL THERAPY MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals & Specialty Clinics
- Research & Academic Institutes
- Biopharmaceutical Companies
- Contract Research Organizations (CROs)
GLOBAL PLACENTAL STEM CELL THERAPY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Hematologic Malignancies and Disorders
- Metabolic Disorders
- Neurological Disorders
- Congenital Immunodeficiency Disorders
- Others
GLOBAL PLACENTAL STEM CELL THERAPY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
